• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • 首都科技期刊卓越行动计划
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020

羊栖菜多糖组分SFP-αⅡ的制备、表征及其免疫增强活性研究

Preparation, Characterization, and Immunoenhancing Activity of Polysaccharide Fraction SFP-αⅡ from Sargassum fusiforme

  • 摘要: 目的:解析羊栖菜多糖的结构特征及体内免疫增强功效。方法:采用水提醇沉法提取,经DEAE-52和Sephadex-G 200分离纯化后得到均一多糖,命名为SFP-αⅡ(糖醛酸含量95.1%)。采用高效凝胶渗透色谱、红外光谱、高效液相色谱、甲基化、核磁共振、刚果红染色、圆二色光谱、原子力显微镜、扫描电镜等分析手段对SFP-αⅡ结构进行鉴定。本研究采用腹腔注射环磷酰胺构建免疫抑制小鼠模型,SFP-αⅡ灌胃干预后检测脾脏指数、胸腺指数、组织结构变化及腹腔巨噬细胞的吞噬能力、NO的生成量、TNF-α及IL-1β水平。结果:SFP-αⅡ是一种分子量为16.5 kDa,结构由主链→1,4)-α-GulA(1→和→1,4)-β-ManA→(33.8:66.2)组成的均一多糖。SFP-αⅡ不具有三螺旋结构,微观结构上呈现出多分枝或网状的螺旋构型,排列紧密并交织构成大小不一的聚集体。小鼠免疫抑制模型表明,SFP-αⅡ干预可以恢复小鼠体质量,脾脏指数和胸腺指数,并有效恢复CTX对小鼠脾脏和胸腺造成的损伤。腹腔巨噬细胞体外培养表明SFP-αⅡ能提高巨噬细胞的吞噬能力、NO分泌量,增加TNF-α和IL-1β的水平,且呈剂量依赖性。结论:SFP-αⅡ可作为一种良好的缓解CTX所引起的免疫抑制副作用的潜在功能性食品。

     

    Abstract: Objective: The aim of this study was to elucidate the structural characteristics and immunomodulatory activities of polysaccharides extracted from Sargassum fusiforme. Methods: A homogeneous fraction designated as SFP-αⅡ (uronic acid content: 95.1%) was obtained from polysaccharides that were extracted by hot water and ethanol precipitation, followed by purification through DEAE-52 cellulose and Sephadex G-200 chromatography. The structural characterization of SFP-αⅡ were investigated by high-performance gel permeation chromatography (HPGPC, homogeneity and Mw), fourier transform infrared (FT-IR, functional group), high-performance liquid chromatography (HPLC, monosaccharide composition), methylation analysis (linkage pattern), nuclear magnetic resonance (NMR, primary structure), congo red assay (triple-helix structure), circular dichroism (CD, helical conformation), atomic force microscopy (AFM, molecular morphology) and scanning electron microscopy (SEM, surface morphology). An immunosuppressed mouse model was established by intraperitoneal injection of cyclophosphamide (CTX), followed by oral administration of SFP-αⅡ. After intervention, the spleen index, thymus index, tissue structure changes, phagocytic ability of peritoneal macrophages, nitric oxide (NO) production, tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) levels were evaluated. Results: SFP-αⅡ was a homogeneous polysaccharide with a molecular weight of 16.5 kDa and had a backbone composed of →1,4)-α-GulA(1→ and →1,4)-β-ManA→ residues in a molar ratio of 33.8:66.2. SFP-αⅡ exhibited no triple-helix conformation, whereas it displayed a multi-branched or network-like helical configuration with densely interwoven aggregates of varying sizes under microscopic observation. In CTX-induced immunosuppressed mice, SFP-αⅡ administration restored body weight, spleen and thymus indices, furthermore markedly ameliorated histological damage to these organs. Moreover, SFP-αⅡ significantly enhanced macrophage phagocytic activity and NO production which elevated TNF-α and IL-1β levels in a dose-dependent manner. Conclusion: SFP-αⅡ exhibited remarkable immunoregulatory activity and effectively alleviated CTX-induced immunosuppression, which indicates its potential as a functional food ingredient for immune support.

     

/

返回文章
返回